General Dynamics receives contract for bioagent detection systems

General Dynamics Armament and Technical Products has been awarded a $30 million contract to produce joint biological point detection systems that will rapidly detect biological warfare agents.

The U.S. Army’s Research, Development and Engineering Command Acquisition Center in Maryland awarded the biodefense firm the contract last month, officials said. The contract could have the potential value of up to $300 million if all options are exercised, the officials said.

General Dynamics has supported the Army’s Joint Biological Point Detection Systems program since 2001. Since that time, General Dynamics has delivered over 700 JBPDS units.

The JBPDS unit is a self contained instrument that is capable of rapidly detecting and identifying biological warfare agents. The JBPDS comes in several forms, ranging from a man-portable model to shelter-based, ship-based and trailer-mounted models, according to General Dynamics officials.

Bill Gural, vice president of detection systems, said he is excited about the contract.

“General Dynamics has and continues to deliver innovations that protect our troops and our country from evolving chemical, biological, and explosive threats,” Gural said. “We look forward to continuing our work with the U.S. Army Research, Development and Engineering Command Acquisition Center for production of JBPDS.”

General Dynamics Armament and Technical Product, headquartered in Charlotte, N.C., designs and produces high-performance armament systems, mobile shelter systems, and biological and chemical detection systems.